grow
need
inform
regard
recent
coronaviru
diseas
present
comprehens
report
patient
iran
one
hundr
hospit
patient
studi
data
potenti
sourc
exposur
demograph
clinic
paraclin
featur
therapi
outcom
postdischarg
followup
analyz
median
age
patient
year
major
patient
year
age
fever
present
patient
admiss
common
clinic
symptom
short
breath
cough
patient
elev
creactiv
protein
elev
erythrocyt
sediment
rate
lymphocytopenia
admiss
lower
lobe
lung
commonli
involv
groundglass
opac
frequent
find
ct
scan
administr
hydroxychloroquin
improv
clinic
outcom
patient
lopinavirritonavir
efficaci
younger
age
discharg
patient
symptom
relaps
readmit
hospit
patient
die
report
demonstr
heterogen
natur
clinic
manifest
patient
affect
common
present
symptom
nonspecif
attent
made
broader
test
especi
age
group
greatest
risk
younger
individu
serv
carrier
diseas
hydroxychloroquin
lopinavirritonavir
younger
age
group
potenti
treatment
option
final
patient
discharg
hospit
follow
potenti
symptom
relaps
coronavirus
second
caus
common
cold
rhinovirus
stricken
global
health
economi
even
previou
one
spread
countriesterritori
infect
million
peopl
around
world
iran
one
sever
affect
countri
viru
previou
studi
describ
clinic
demograph
characterist
diseas
inform
regard
transmiss
pattern
mostli
relat
china
also
lack
inform
potenti
treatment
outcom
posthospit
followup
literatur
studi
one
first
report
patient
iran
report
detail
inform
potenti
sourc
exposur
household
contact
inform
outcom
potenti
therapi
postdischarg
followup
well
demograph
clinic
paraclin
characterist
medic
record
suspect
case
februari
march
admit
ya
hospit
affili
tehran
univers
medic
scienc
review
hospit
first
center
tehran
care
adult
patient
suspect
case
defin
flulik
syndrom
symptomat
patient
along
radiolog
pulmonari
find
data
patient
result
reversetranscriptasepolymerasechainreact
rtpcr
avail
exclud
studi
confirm
use
rtpcr
nasopharyng
specimen
studi
approv
tehran
univers
medic
scienc
tum
ethic
committe
inform
consent
obtain
patient
firstdegre
rel
unconsci
patient
patient
came
hospit
examin
infectiousdiseas
specialist
classifi
three
group
accord
diseas
sever
base
iran
nation
guidelin
diagnosi
treatment
outpati
inpati
patient
assign
moder
sever
infect
group
admit
hospit
patient
occup
travel
histori
within
past
day
household
contact
inform
demograph
characterist
potenti
sourc
exposur
influenza
vaccin
histori
current
list
medic
past
medic
histori
social
histori
use
prevent
measur
determin
histori
present
ill
comprehens
review
system
taken
complet
physic
examin
done
clinic
laboratori
studi
chest
comput
tomographi
ct
scan
request
first
day
admiss
accord
infecti
diseas
specialist
recommend
collect
hospit
data
use
patient
paper
medic
record
avail
ct
scan
report
radiologist
score
sever
locat
involv
final
report
review
infecti
diseas
specialist
pulmonologist
main
treatment
medic
includ
oseltamivir
twice
daili
hydroxychloroquin
twice
daili
mg
singl
dose
combin
administr
lopinavirritonavir
lopinavirritonavir
mg
mg
ritonavir
twice
daili
ribavirin
mg
twice
daili
accord
nation
guidelin
patient
classifi
three
group
mild
moder
sever
diseas
treatment
regimen
admissiondischarg
criteria
accord
iran
nation
guidelin
novel
coronaviru
infect
definit
mild
moder
sever
diseas
accord
nation
guidelin
patient
flulik
syndrom
withwithout
fever
sign
infiltr
lung
imag
classifi
mild
diseas
moder
group
defin
symptomat
patient
pulmonari
infiltr
least
one
admiss
criteria
explain
figur
sever
group
constitut
patient
least
one
follow
criteria
reduc
conscious
respiratori
rate
rr
blood
pressur
bp
bp
multi
lobular
infiltr
hypoxemia
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
also
conduct
telephon
survey
patient
discharg
hospit
questionnair
develop
follow
patient
day
postdischarg
ask
patient
episod
symptom
relaps
need
hospit
readmiss
whether
complet
day
home
quarantin
discharg
discharg
patient
follow
march
critic
situat
patient
defin
admiss
intens
care
unit
use
mechan
ventil
death
consid
primari
composit
endpoint
compar
demograph
characterist
hospit
data
potenti
treatment
outcom
critic
ill
noncrit
ill
patient
postdischarg
followup
report
discharg
patient
index
patient
defin
first
person
household
diagnos
use
rtpcr
incub
period
calcul
time
last
potenti
exposur
time
show
first
diseas
symptom
lung
lobar
score
calcul
use
score
system
give
five
lobe
score
grade
accord
sever
involv
lobe
involv
involv
involv
involv
involv
sum
lobar
score
combin
defin
total
lung
score
estim
sever
entir
lung
involv
provid
score
lower
lobe
score
defin
sum
right
lower
lobe
left
lower
lobe
score
provid
score
middl
lobe
score
defin
right
middl
lobe
score
provid
score
upper
lobe
score
defin
sum
right
upper
lobe
left
upper
lobe
score
provid
score
laboratori
confirm
perform
nation
influenza
center
locat
school
public
health
tehran
univers
medic
scienc
nasopharyng
swab
specimen
collect
hospit
patient
use
dacron
steril
swab
place
cc
viral
transport
media
sent
laboratori
cold
condit
sampl
subject
rna
extract
high
pure
viral
nucleic
acid
kit
roch
germani
accord
manufactur
instruct
realtim
rt
pcr
use
detect
presenc
kit
modulardx
kit
wuhan
cov
e
rdrp
gene
provid
target
e
region
screen
rna
depend
rna
polymeras
confirm
invitrogen
superscript
iii
onestep
rtpcr
system
platinum
taq
dna
polymeras
use
pcr
reaction
reaction
mix
rt
enzym
primer
probe
mix
pcr
grade
water
ad
rna
templat
cycl
condit
amplif
e
rdrp
gene
min
min
cycl
cycl
threshold
valu
less
ct
defin
posit
test
result
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
nonparametr
test
includ
fisher
exact
test
mannwhitney
u
test
friedman
test
use
analyz
data
cross
tabul
fisher
exact
test
use
investig
relat
binari
variabl
mannwhitney
u
test
appli
compar
quantit
variabl
two
group
median
interquartil
rang
iqr
present
result
ct
scan
analysi
friedman
test
use
compar
differ
lung
lobe
involv
comparison
tripl
accumul
score
addit
logist
regress
use
estim
effect
treatment
odd
ratio
scale
use
backward
wald
elimin
variabl
regress
model
respons
variabl
consid
binari
variabl
either
case
discharg
recoveri
case
death
administ
medic
hydroxychloroquin
lopinavirritonavir
ribavirin
antibiot
enter
regress
model
binari
independ
variabl
patient
age
coexist
disord
includ
hypertens
diabet
copdasthma
consid
covari
variabl
interact
age
patient
condit
critic
ill
vs
noncrit
ill
medic
hydroxychloroquin
lopinavirritonavir
ribavirin
includ
model
also
order
examin
simultan
effect
hydroxychloroquin
azithromycin
interact
two
variabl
consid
model
analysi
perform
use
spss
softwar
version
ibm
studi
includ
hospit
patient
admit
patient
februari
march
figur
show
distribut
index
patient
district
tehran
surround
areasc
district
affect
district
tehran
follow
district
find
show
patient
either
live
visit
neighbor
area
within
day
prior
admiss
five
patient
link
citi
qom
epicent
diseas
iran
recent
potenti
exposur
household
contact
inform
demograph
clinic
characterist
laboratori
radiolog
find
patient
outcom
extract
shown
clinic
paraclin
treatment
outcom
also
compar
two
group
discharg
deceas
patient
see
tabl
supplementari
appendix
median
age
patient
year
rang
major
patient
year
age
critic
ill
patient
older
noncrit
ill
group
vs
p
male
constitut
major
patient
median
famili
member
person
iqr
household
total
famili
member
femal
male
identifi
live
household
index
patient
year
age
accord
job
classif
patient
low
exposur
risk
occup
high
exposur
risk
occup
medic
staff
potenti
exposur
contact
suspect
famili
member
contact
underag
famili
member
upper
respiratori
infect
symptom
nineteen
patient
live
tehran
recent
histori
domest
travel
recent
oversea
travel
none
patient
recent
travel
china
qom
mark
epicent
iran
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
median
incub
period
day
iqr
fever
present
patient
admiss
common
clinic
symptom
short
breath
cough
myalgia
decreas
level
conscious
evid
among
critic
ill
patient
compar
among
noncrit
ill
group
p
furthermor
respiratori
rate
higher
critic
ill
patient
compar
noncrit
ill
group
median
vs
p
presenc
coexist
disord
higher
critic
ill
group
statist
signific
vs
rel
risk
critic
ill
group
confid
interv
ci
p
laboratori
test
admiss
show
patient
lymphocytopenia
elev
creactiv
protein
elev
erythrocyt
sediment
rate
elev
lactat
dehydrogenas
level
median
level
whitecel
count
median
neutrophil
count
statist
differ
two
group
critic
noncrit
ill
patient
p
p
respect
abnorm
creatinin
level
percentag
higher
critic
patient
compar
noncrit
one
rel
risk
critic
ill
group
confid
interv
ci
total
ct
scan
review
score
expert
radiologist
nonparametr
friedman
test
show
differ
involv
term
lobar
predomin
right
lower
left
lower
lobe
involv
lobe
follow
right
middl
lobe
right
upper
lobe
left
upper
lobe
respect
p
also
test
show
differ
three
cumul
score
median
lower
lobe
score
highest
score
follow
median
upper
lobe
score
median
middl
lobe
score
respect
p
groundglass
opac
common
radiolog
find
follow
mix
pattern
groundglass
opac
consolid
crazi
pave
appear
found
equal
result
group
critic
ill
vs
noncrit
ill
similar
ct
scan
find
patient
receiv
oseltamivir
recommend
medic
accord
nation
guidelin
main
administ
medic
includ
hydroxychloroquin
lopinavirritonavir
ribavirin
administ
patient
intraven
antibiot
also
administ
shown
tabl
patient
receiv
supplementari
oxygen
therapi
base
patient
condit
intraven
fluid
therapi
given
routin
mainten
mention
solut
type
volum
tabl
total
patient
alreadi
take
losartan
angiotensinconvertingenzym
inhibitor
ace
inhibitor
due
hypertens
continu
hospit
cours
losartan
vs
ace
inhibitor
mechan
ventil
use
patient
noninvas
ventil
vs
invas
ventil
hydroxychloroquin
ci
interact
lopinavirritonavir
age
sever
ci
signific
effect
odd
ratio
howev
interact
azithromycin
hydroxychloroquin
signific
effect
model
ci
tabl
show
first
last
step
backward
elimin
regress
analysi
valu
nagelkerk
r
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
final
model
cox
snell
r
valu
show
good
fit
model
patient
admit
hospit
studi
period
patient
elig
patient
die
patient
discharg
date
data
cut
caus
death
follow
five
patient
due
acut
respiratori
distress
syndrom
patient
die
septic
shock
patient
die
due
cardiac
arrhythmia
die
pneumothorax
two
remain
patient
die
sudden
cardiac
arrest
seventi
patient
follow
within
day
discharg
date
thirtysix
patient
observ
day
home
quarantin
postdischarg
symptom
relaps
patient
short
breath
cough
common
symptom
relaps
discharg
six
patient
readmit
hospit
patient
die
postdischarg
tabl
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
patient
ask
whether
complet
day
home
quarantin
discharg
c
could
determin
caus
death
patient
die
postdischarg
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
hospit
first
center
care
new
case
appear
tehran
iran
present
first
case
patient
tehran
identifi
common
sourc
exposur
detail
clinic
paraclin
find
clinic
outcom
common
propos
antivir
therapi
postdischarg
followup
import
find
consist
posit
effect
hydroxychloroquin
lopinavirritonavir
diseas
outcom
find
concord
previou
studi
hydroxychloroquin
show
efficaci
diseas
outcom
furthermor
cao
et
al
conclud
lopinavirritonavir
efficaci
howev
data
assess
relat
individu
patient
paramet
regress
model
identifi
age
determin
respons
lopinavirritonavir
efficaci
relat
younger
age
age
identifi
import
determin
mortal
show
younger
age
also
determin
respons
antivir
therapi
lopinavirritonavir
also
use
model
determin
efficaci
combin
azithromycinhydroxychloroquin
regimen
found
combin
signific
clinic
outcom
contrari
current
protocol
previou
studi
second
signific
find
symptom
relaps
patient
discharg
common
relaps
symptom
cough
short
breath
six
patient
readmit
hospit
patient
die
discharg
emphas
need
close
followup
symptom
improv
lan
et
al
show
certain
patient
could
recov
test
neg
test
posit
phenomenon
might
underli
symptom
rebound
patient
might
indic
patient
still
sourc
transmiss
recov
next
signific
find
studi
greater
preval
higher
socioeconom
neighborhood
would
expect
lower
socioeconom
segment
tehran
import
transmiss
studi
found
contrari
may
explain
greater
number
crowd
area
like
shop
mall
hospit
affluent
area
comparison
less
affluent
area
furthermor
major
patient
follow
prevent
measur
use
medic
mask
use
alcoholbas
hand
rub
wash
hand
regularli
emphas
import
prevent
measur
fever
present
less
half
patient
admiss
common
clinic
symptom
short
breath
cough
data
fever
similar
guan
et
al
report
fever
admiss
differ
chen
et
al
wang
et
al
report
respect
might
indic
fever
specif
find
howev
cough
consist
promin
clinic
symptom
sever
diseas
directli
relat
patient
age
year
higher
respiratori
rate
decreas
level
conscious
consist
previou
studi
lymphocytopenia
common
laboratori
find
may
serv
specif
marker
begin
infect
consid
previou
studi
howev
absent
studi
popul
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
abnorm
creatinin
level
higher
white
cell
count
higher
neutrophil
count
seen
critic
ill
patient
may
explain
direct
renal
involv
fluid
imbal
secondari
critic
ill
statu
patient
increas
wbc
count
critic
ill
patient
predomin
neutrophil
sign
secondari
bacteri
infect
chest
ct
scan
analysi
reveal
higher
involv
lower
lung
lobe
compar
right
middl
upper
lung
lobe
common
find
groundglass
opac
presenc
groundglass
opac
bilater
lower
lobe
involv
common
radiograph
find
patient
similar
xu
et
al
use
diagnost
factor
covid
limit
first
access
review
ct
scan
sinc
perform
outsid
refer
hospit
second
limit
number
laboratori
studi
due
high
patient
load
limit
resourc
third
mani
patient
exclud
due
lack
pcr
kit
onset
epidem
tehran
fourth
patient
medic
record
complet
due
emerg
situat
fifth
mani
patient
unabl
rememb
initi
exposur
sixth
could
determin
caus
death
patient
die
postdischarg
present
heterogen
pattern
nonspecif
find
affect
older
individu
advers
high
risk
diseas
relaps
necessit
close
monitor
discharg
patient
rush
find
effect
therapi
medic
commun
activ
test
numer
repurpos
novel
drug
